Skip to content
doi.org· The Journal of experimental medicine·· 21 hours agoPickScore72

Colorectal cancers with distinct metastatic potential trigger divergent early T cell responses

In brief

Colorectal cancers with different metastatic potential induce different early T cell responses: nonmetastatic tumors trigger cytotoxic and Th1-like programs, while pro-metastatic tumors leave T cells in a naïve-like, hypoactivated state. Using orthotopic organoid transplantation and T cell fate-mapping, the study found that pro-metastatic tumors downregulate MHCII, and targeting Ciita weakened CD4+ clonal expansion in nonmetastatic organoids and promoted tumor progression.

Why it matters

Using orthotopic organoid transplantation and T cell fate-mapping, the study contrasted early immune responses to nonmetastatic and pro-metastatic tumors and identified MHCII downregulation as the mechanistic difference.

Source: doi.org · doi.org

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.